(168 days)
No
The document describes a standard infrared heat lamp device with a user interface for controlling parameters. There is no mention of AI, ML, image processing, or any data-driven decision-making processes. The performance study focuses on equivalence to predicate heat lamps, not on algorithmic performance.
Yes
The device is described as providing "temporary relief of minor muscle and joint pain and stiffness," "temporary relief of minor joint pain associated with arthritis," and "relaxation of muscles," which are therapeutic claims.
No
The 'Intended Use / Indications for Use' section describes the device's purpose as providing topical heating for pain relief, increased local circulation, and muscle relaxation. These are therapeutic uses, not diagnostic ones. There is no mention of the device being used to identify or analyze a condition.
No
The device description explicitly states the system consists of a laser unit, footswitch, handpiece, and user interface panel on top of the laser unit, all of which are hardware components.
No, this device is not an IVD (In Vitro Diagnostic).
Here's why:
- IVD Definition: In vitro diagnostics are tests performed on samples such as blood, urine, or tissue that have been taken from the human body to detect diseases or other conditions.
- ThermaPulse™ Function: The ThermaPulse™ is described as a device that emits infrared energy for topical heating to provide temporary relief of pain and stiffness. It works by applying energy directly to the body's surface.
- Lack of Sample Analysis: There is no mention of the ThermaPulse™ analyzing any biological samples (blood, urine, tissue, etc.) taken from the patient. Its function is entirely external and therapeutic.
The description clearly indicates a therapeutic device that applies energy to the body, not a diagnostic device that analyzes samples from the body.
N/A
Intended Use / Indications for Use
The ThermaPulse™ at the power settings in the range of 5-50 Watts (power density 75-500 mW/cm2) is intended to emit energy in the infrared spectrum to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of minor muscle and joint pain and stiffness. the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of muscles. In addition, the ThermaPulse™ may also help muscle spasms, minor sprains and strains, and minor muscular back pain.
Product codes
ILY
Device Description
The ThermaPulse™ delivers infrared light with a wavelength of 810 +/-20 nm.
The complete system consists of a laser unit, a ThermaPulse™ footswitch, and a handpiece connected to the laser unit with an umbilical. In standard use, the ThermaPulse is positioned at an average distance of 23 cm from the treatment area. The ThermaPulse is equipped with a fan to offer greater patient's comfort. System parameters and other features are controlled from the user interface panel on top of the laser unit, which provides an interface to the system computer.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
Not Found
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Performance Data: differences in the specifications of the The ThermaPulseTM and the predicate devices do not result in different performance or raise new questions of safety or efficacy. Conclusion: Based on the foregoing, the ThermaPulse™ is substantially equivalent to the legally-marketed claimed predicate devices.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 890.5500 Infrared lamp.
(a)
Identification. An infrared lamp is a device intended for medical purposes that emits energy at infrared frequencies (approximately 700 nanometers to 50,000 nanometers) to provide topical heating.(b)
Classification. Class II (special controls). The device, when it is an infrared therapeutic heating lamp, is exempt from the premarket notification procedures in subpart E of part 807 of this chapter subject to the limitations in § 890.9.
0
024179/51 1/2
JUN - 4 2003
Attachment 4
510(K) Summary of Safety and Effectiveness
This 510(K) Summary of Safety and Effectiveness for the Palomar SLP 1000 ThermaPulse™ is submitted in accordance with the requirements of Safe Medical Device Act (SMDA) of 1990 and follows the Office of Device Evaluation (ODE) guidance concerning the organization and content of a 510(K) summary.
| Applicant: | Palomar Medical Technologies, Inc. |
|---|---|
| Address: | 82 Cambridge St. |
| Burlington, MA 01803 | |
| Contact Person: | Marcy Moore |
| Telephone: | 919-363-2432 |
| Preparation Date: | December 12, 2002 |
| Device Trade Name: | Palomar ThermaPulse™ |
| Common Name: | ThermaPulse™ |
| Classification Name: | Infrared Heating Lamp (see: 21 CFR 890.5500) |
| Legally-Marketed Predicate Device: | K020851-TDP Heat Lamp; K021956, MHS Med |
| Light 1000; K003538, TDP CQ-27 Heat Lamp |
System Description:
The ThermaPulse™ delivers infrared light with a wavelength of 810 +/-20 nm.
The complete system consists of a laser unit, a ThermaPulse™ footswitch, and a handpiece connected to the laser unit with an umbilical. In standard use, the ThermaPulse is positioned at an average distance of 23 cm from the treatment area. The ThermaPulse is equipped with a fan to offer greater patient's comfort. System parameters and other features are controlled from the user interface panel on top of the laser unit, which provides an interface to the system computer.
1
024179/81 4/2
Intended Use of the Device:
The ThermaPulse™ at the power settings in the range of 5-50 Watts (power density 75-500 mW/cm2) is intended to emit energy in the infrared spectrum to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of minor muscle and joint pain and stiffness. the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of muscles. In addition, the ThermaPulse™ may also help muscle spasms, minor sprains and strains, and minor muscular back pain.
Performance Data: differences in the specifications of the The ThermaPulseTM and the predicate devices do not result in different performance or raise new questions of safety or efficacy. Conclusion: Based on the foregoing, the ThermaPulse™ is substantially equivalent to the legally-marketed claimed predicate devices.
2
Image /page/2/Picture/1 description: The image is a black and white logo for the U.S. Department of Health & Human Services. The logo consists of a circular border with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES - USA" around the edge. Inside the circle is a stylized symbol that resembles an abstract human figure or a bird in flight, composed of three curved lines.
Food and Drug Administration 9200 Corporate Boulevard Rockville MD 20850
JUN - 4 2003
Ms. Marcy Moore Manager of Clinical Studies Palomar Medical Technologies, Inc. 131 Kelekent Lane Cary, North Carolina 27511
Re: K024179
Trade/Device Name: Palomar ThermaPulseTM Regulation Number: 21 CFR 890.5500 Regulation Name: Infrared heating lamp Regulatory Class: II Product Code: ILY Dated: March 5, 2003 Received: March 6, 2003
Dear Ms. Moore:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food, Drug, and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration.
If your device is classified (see above) into either class II (Special Controls) or class III (PMA), it may be subject to such additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820); and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
3
Page 2 - Ms. Marcy Moore
This letter will allow you to begin marketing your device as described in your Section 510(k) premarket notification. The FDA finding of substantial equivalence of your device to a legally marketed predicate device results in a classification for your device and thus, permits your device to proceed to the market.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please contact the Office of Compliance at (301) 594-4659. Additionally, for questions on the promotion and advertising of your device, please contact the Office of Compliance at (301) 594-4639. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97) you may obtain. Other general information on your responsibilities under the Act may be obtained from the Division of Small Manufacturers. International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 443-6597 or at its Internet address http://www.fda.gov/cdrh/dsma/dsmamain.html
Sincerely vours.
Mark McMullen
Celia M. Witten, Ph.D., M.D. Director Division of General, Restorative and Neurological Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
4
INDICATIONS FOR USE STATEMENT
510(K) Number: K024179
ThermaPulse™ Device Name:
Indications for Use:
The ThermaPulse™ at the power settings in the range of 5-50 Watts is intended to emit energy in the infrared spectrum to provide topical heating for the purpose of elevating tissue temperature for the temporary relief of minor muscle and joint pain and stiffness, the temporary relief of minor joint pain associated with arthritis, the temporary increase in local circulation where applied, and the relaxation of muscles. In addition, the ThermaPulse™ may also help muscle spasms, minor sprains and strains, and minor muscular back pain.
(Please do not write below this line - Continue on another page if needed)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Prescription Use
OR
Over-the-Counter Use
(per 21 CFR 801.109)
(Division Sigr
Division of G Restorative
and Neurological Devices
Number K024179